The Algocyte® Team
We are passionate about the use of science and computational intelligence to push the boundaries of medical understanding and diagnostics. We aim to become a trusted provider of responsible and clinically validated tools to improve healthcare worldwide for early diagnosis, better disease treatment, and equal access to the best medical advice.
The Founder
With over 130 papers published in journals such as Nature and the Royal Society and multiple granted patents in the field of medical devices, Dr. Hector Zenil FMRS, is the world leader in the development of methods and applications of optimal inference theory applied to scientific discovery, computational medicine and systems biology in application to blood, cell and molecular biology.
He introduced the field of Algorithmic Information Dynamics based upon a theory called Algorithmic Probability that underpins all AI, AGI, and Artificial Super Intelligence and was originally introduced by the founders of computer science, some of whom were the academic supervisors of Dr. Zenil’s two PhD degree committees.
Algorithmic probability is the other side of Kolmogorov-Chaitin complexity. Gregory Chaitin, a founder of modern computer science, was a supervisor of Dr. Zenil. Dr. Zenil has been mostly influenced by Chaitin and Stephen Wolfram with whom has worked for over 20 years after he mentored in 2005 and hired him in his Think Tank in his personal office in Boston. Today, Dr. Zenil is the Editor-in-Chief of the first journal in the field of Complex Systems founded by Wolfram in 1987.
Research
The team exploits its research experience carried out at top-ranked institutions at the forefront of AI and medicine, including Oxford, Cambridge, KCL and the Karolinska Institute , the institute that awards the Nobel Prize in Medicine or Physiology, by combining it with their experience in industry at leaders of computational intelligence and medical device innovation.
Our founder and team leaders have published over 300 papers in all the top-ranked journals in the areas of Artificial Intelligence, precision medicine, and systems immunology.
Integrative Teams
Our cross-disciplinary team consists of AI experts, medical leaders, and pioneers in IoT and engineering working at the forefront of science and technology. With our multidisciplinary approach, we tackle some of the most pressing human health challenges, such as infection, cancer, antibiotic resistance, and tropical diseases from a technological and commercial-viability point of view.
Our Team
Dr. Hector Zenil
Founder and Chief Visionary Officer
Ph.D. in Computer Science (Lille) & Ph.D. in Logic (Paris Sorbonne). Associate Professor in Bio and Healthcare Engineering at King’s College London. Former lab leader & senior researcher affiliated with five of the world’s top universities in AI (Cambridge, Oxford, MIT, CMU) & Medicine (Karolinska). He wrote code behind Siri, Alexa, and ChatGPT that deals with factual contextual questions. He was a Payload team member for the NASA Mars Biosatellite project at MIT. He is a board and advisor member of multiple startups around the world.
Pamela Winsor
Strategic Advisor
eMBA (2000) at St. Mary’s University, Halifax and the ICD.D (2015) with Rotman School of Business, Toronto. 20+ years as a Senior Healthcare Executive, including 14 years at Medtronic as CMO, the world largest medical device manufacturer. Member of the Canadian College of Health Leaders, and a leader visionary in patient-centric healthcare. Rotman, Judy Project Alumni and an executive coach.
Allan Bezanson
Director
Director of several public and private companies. He has a background in private equity & financial services with a demonstrated history of successfully building businesses as a leader and investor. Notable past successes Nowsco, Altus, Bluewave Energy, FCF Capital, Polaris, and Voxtur.
Abel Archundia
Advisor
Former Head of Digital Transformation and IT for Bayer Pharmaceuticals. He is a member of the group’s Digital Transformation Board as well as a member of the Bayer Group IT board. Former Global Head, Novartis TechOps/QA IT and Sandoz Division IT of Novartis. Former supply chain manager for Dell and as General Manager (US$500M business) on the vendor side. Chief Information Officer with broad experience (geo, functional & business), especially in large-scale transformation efforts (PMIs, IT Transformation, process governance).
John Cullen
Board Chair
Current CEO of JHI Associates. 30+ years experience in public company financing, corporate/ capital structuring and management 20+ years corporate experience in the energy sector. Founded a number of public international resource companies following 15 years in the Canadian investment industry.
Prof. Jesper N. Tegnér
Director
Ph.D. in neurosciences (Karolinska). Professor of Bioscience and Computer Science (KAUST) specialised in AI applied to systems medicine and single-cell genomics. Founder of award-winning startups in Sweden. Chaired full professorship in Computational Biology, the first of its kind in Sweden and Strategic chaired full professor in Computational Medicine, Karolinska Institutet & Division of Clinical Epidemiology, Karolinska Hospital.
Dr. Roger Ferguson, Jr.
Observer
J.D., and a Ph.D. in economics (Harvard). He has a significant stake in OIA as the second-largest individual shareholder after the Founder. Past President and CEO of TIAA, a Fortune 100 financial services organization. Former head of financial services for Swiss Re and Chairman of Swiss Re America Holding Corporation. Former Vice Chairman of the Board of Governors of the U.S. Federal Reserve. He serves on the boards of Alphabet, Inc. and on the boards of the Institute for Advanced Study, and Memorial Sloan Kettering Cancer Center, among others.
Dr. Pradip Banerjee
Director
A visionary C-Suite leader, seasoned board director, and serial venture creator with 30+ years of experience in building, scaling, and exiting companies across life sciences, SaaS, and healthcare technology. He served as Chairman & CEO of Xybion Digital Inc., where he transformed a $4M niche SaaS provider into a global market leader serving 350+ enterprise clients across 35 countries and a landmark 40X+ MOIC exit. During his career, as Founding Managing Partner at Accenture, he launched and scaled the firm’s Life Sciences R&D consulting business into a $1B global unit.
Prof. Kourosh Saeb-Parsy
Chief Medical Officer
MD & PhD in (neurosciences). Professor in Transplantation, group leader, Department of Surgery, Cambridge University. NHS Consultant Transplant Surgeon. Specialises in immunogenicity of cancer and regenerative cellular therapies. Multiple experience leading start-ups to success.
Prof. Petter Brodin
Garfield Weston Chair & Professor of Paediatric Immunology (Imperial College) & Professor of Paediatric immunology (Karolinska Institutet). Develops novel methods to describe human immune system variation
Dr. Sam Toney
Chief Medical Officer of Carespan has over thirty years of clinical management experience in health plan populations including Medicare, Medicaid, Tricare and commercial lines of business. Frequent speaker at Medicaid Managed Care Congress and Medicaid Health Plans of America Conference, and has presented on national webinars for Health Plan Alliance
Dr. Rolf Porsche
Physician, healthcare strategist, and innovation leader. He has served in senior roles including at IBM Global Business Services as Partner and Head of Healthcare Consulting, where he drove strategic initiatives at the interface of medicine and technology. He has supported, managed and drove projects achieving an overall revenue of over €100 billion.
Prof. Patrick Tighe
Professor of Molecular Immunology (Nottingham) specialised in molecular cloning, T cell receptor analysis, fluorescent detection technologies & immunoassay tech.
Dr. Jason Berman
Full Professor of Paediatrics and Cellular & Molecular Medicine at the University of Ottawa. Clinician, researcher and thought leader. Serves as CEO & Scientific Director of the Children’s Hospital of Eastern Ontario (CHEO).
Dr. Corey Cutler
MD, MPH, FRCP(C) is the Medical Director of the Stem Cell Transplantation Program at the Dana-Farber Cancer Institute & an Associate Professor of Medicine at Harvard Medical School. Author of 300+ publications and 40 reviews and book chapters.
Dr. Narsis A. Kiani
Lab leader and senior researcher at the Department of Oncology-Pathology and the Algorithmic Dynamics Lab, Karolinska Institute. BEng in medical engineering and a BSc in pure mathematics, MSc, and PhD in applied mathematics. She was a VINNMER (Vinnova-Marie curie) Fellow.
Tony Cambridge
Tony Cambridge is the Managing Director of Thornhill Healthcare Events & Consultancy, and Lead Biomedical Scientist in the Pathology Management team of a major trauma centre and acute care NHS hospital in England. With over 25 years’ experience in pathology & diagnostics.
Prof. Weizi Li
Associate Professor of Informatics & Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. Principal Investigator of the EPSRC project on the ‘Future blood testing for inclusive monitoring and personalised analytics Network+’.
Martin Korbmacher
Founder and Managing Partner of Event Horizon Capital & Advisory GmbH. Event Horizon is a Corporate Finance Boutique as well as an investment vehicle. He holds the position of Chairman of the supervisory board of the publicly listed flatexDEGIRO AG, and is also Chairman of the supervisory board of the publicly listed SGT Private Equity GmbH & Co. KGaA.
Rembert de Villa
Has held leadership roles at EXL Healthcare, Mastercard, and Capgemini. He serves on several boards, including Carespan and the Joseph Brant Hospital Foundation
Dr. Syed Ahsan Raza
Senior Clinical Scientist at the Trauma and Transfusion Medicine Research Center, University of Pittsburgh, with expertise spanning from epidemiology (Ph.D.), to infection disease, big data analytics, clinical adaptive trials, Bayesian analysis, and AI. Former researcher (cancer) at Baylor College of Medicine from where he received his MD followed by postgraduate studies at Harvard. Over 50 peer-reviewed publications.
Dr. Andrew King
Consultant haematologist and clinical lead for haemato-oncology at Cambridge University Hospitals NHS Foundation Trust. Specialised in acute leukaemia, myeloma and bone marrow, transplantation/cellular therapy. Principal or sub-investigator on several late phase clinical trials. DPhil in molecular biology at the Weatherall Institute, University of Oxford. Co-author of Lecture Notes in Haematology.
Dr. Hamid Sadri
Hamid Sadri is the Director of Policy, Health Economics & Outcomes Research at Medtronic ULC. Holds a doctorate in clinical pharmacy and two graduate degrees, in health economics and healthcare management respectively, from the University of Toronto. He is is a registered pharmacist in Ontario and is a member of the
Canadian College of Health Leaders.
OIA Centres
Headquartered outside London in the UK & operating in several countries.
Oxford Immune Algorithmics Ltd
Davidson House, Forbury Square, RG1, 3EU, Reading UK
Head Office
Oxford Immune Algorithmics Ltd
6 Richfield Place, 12 Richfield Avenue
RG1 8EQ, Reading
UK
Global HQs & Biolab
AI Research and
Software Development
AI Research Center
Immune Algorithmics Middle
East. PO Box: 46617, 15th Floor, WeWork Hub71
Abu Dhabi, UAE
OIA France
8 Avenue des Champs-Élysées
75008 Paris
France
Commercial
Algocyte Canada
130 Adelaide Street West, Suite 3002 Toronto, ON
Canada M5H 3P5